Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV
Por um escritor misterioso
Descrição
Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines
Vaccines, Free Full-Text
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial - eClinicalMedicine
Vaccines, Free Full-Text
Frontiers Viral vector and nucleic acid vaccines against COVID-19: A narrative review
Current clinical status of new COVID-19 vaccines and immunotherapy
Enhanced immunogenicity elicited by a novel DNA vaccine encoding the SARS- CoV-2 S1 protein fused to the optimized flagellin of Salmonella typhimurium in mice
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure
A brief review on DNA vaccines in the era of COVID-19
Advancements in DNA vaccines against COVID-19
Phase 1 U.S. Trial of COVID-19 DNA Vaccine Enrollment Complete
de
por adulto (o preço varia de acordo com o tamanho do grupo)
